Home / About / Awards & Recognition / ACCC Innovator Awards / 2024 Winners / The Ohio State University Comprehensive Cancer Center

The Ohio State University Comprehensive Cancer Center

 

The-Ohio-State-University-300x132

Sarah Hudson-DiSalle, PharmD, RPh, FACCC
Assistant Director of Reimbursement Services
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

Leveraging the EHR to Automate Biosimilar Selection and Streamline the Prior Authorization Process

This rule-based informatics solution pulls from the electronic health record to automate the election of an appropriate biosimilar therapy based on the patient’s insurance and hospital formulary preferences, streamlining prior authorization and approval processes. This e-tool decreased administrative burden to providers, pharmacists, and prior authorization specialists and increased biosimilar utilization by 21.9%.

Watch Video

Read Blog

Leveraging the EHR to Automate Biosimilar Selection

ACCCBuzz spotlights The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a recipient of the 2024 ACCC Innovator Award.
Read Full Story